Experts demand generic version of drug effective against Covid-19
SATURDAY, APRIL 10, 2021
Shouldn't a medicine like Remdesivir, which has proved to be life-saving in certain cases of Covid-19, be made available to all those who need it without delay?
The Food and Drug Administration approved Gilead Sciences Inc.'s antiviral therapy remdesivir on Thursday, making it the first drug to obtain formal clearance for treating the coronavirus.
Covid-19 treatment remdesivir priced at $3,120 for the typical patient
MONDAY, JUNE 29, 2020
Gilead Sciences, the maker of the first covid-19 treatment found to have worked in clinical trials, said it will charge U.S. hospitals $3,120 for the typical patient with private insurance.
Taxpayers paid to develop remdesivir but will have no say when Gilead sets price
WEDNESDAY, MAY 27, 2020
The drug that buoyed expectations for a coronavirus treatment and drew international attention for Gilead Sciences, remdesivir, started as a reject, an also-ran in the search for antiviral drugs. Its path to relevance did not begin until Robert Jordan cleared it.
Chula virologist appeals for blood plasma donations to treat Covid-19 patients
SATURDAY, APRIL 18, 2020
Covid-19 is a new disease caused by a virus, so there is no specific treatment, Dr Yong Poovorawan, an expert virologist at Chulalongkorn University, said while advocating the use of plasma to treat patients.